MedPath

Eastern Cooperative Oncology Group

Eastern Cooperative Oncology Group logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
2012-01-01
Employees
51
Market Cap
-
Website
https://ecog-acrin.org

Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer

Phase 2
Withdrawn
Conditions
Lung Cancer
First Posted Date
2007-05-07
Last Posted Date
2015-10-08
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00469976

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Phase 2
Completed
Conditions
Islet Cell Tumor
Neoplastic Syndrome
Gastrointestinal Carcinoid Tumor
Interventions
First Posted Date
2007-01-29
Last Posted Date
2023-07-05
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
46
Registration Number
NCT00427349
Locations
🇺🇸

Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States

🇺🇸

Associates in Womens Health, PA - North Review, Wichita, Kansas, United States

🇺🇸

Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States

and more 109 locations

Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2006-10-13
Last Posted Date
2015-04-28
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
79
Registration Number
NCT00387699

Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

Phase 2
Completed
Conditions
Carcinoma of Unknown Primary
Pain
First Posted Date
2006-07-27
Last Posted Date
2020-11-02
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
52
Registration Number
NCT00357630
Locations
🇺🇸

Elkhart General Hospital, Elkhart, Indiana, United States

🇺🇸

CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States

🇺🇸

Memorial Hospital of South Bend, South Bend, Indiana, United States

and more 34 locations

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

First Posted Date
2006-06-08
Last Posted Date
2023-07-03
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
26
Registration Number
NCT00335140
Locations
🇺🇸

West Michigan Cancer Center, Kalamazoo, Michigan, United States

🇺🇸

Minnesota Oncology Hematology, PA - Woodbury, Woodbury, Minnesota, United States

🇺🇸

Bronson Methodist Hospital, Kalamazoo, Michigan, United States

and more 65 locations

Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance

Completed
Conditions
Cognitive/Functional Effects
Psychosocial Effects of Cancer and Its Treatment
Spiritual Concerns
Cancer Survivor
Sexuality and Reproductive Issues
Breast Cancer
First Posted Date
2006-04-03
Last Posted Date
2023-06-18
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
2697
Registration Number
NCT00309933
Locations
🇺🇸

St. Luke's Regional Medical Center, Sioux City, Iowa, United States

🇺🇸

Borgess Medical Center, Kalamazoo, Michigan, United States

🇺🇸

Bronson Methodist Hospital, Kalamazoo, Michigan, United States

and more 101 locations

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Completed
Conditions
Psychosocial Effects of Cancer and Its Treatment
Cognitive/Functional Effects
Lung Cancer
Prostate Cancer
Breast Cancer
Pain
Colorectal Cancer
First Posted Date
2006-03-17
Last Posted Date
2023-06-18
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
2310
Registration Number
NCT00303914
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

🇺🇸

Elkhart General Hospital, Elkhart, Indiana, United States

🇺🇸

Saint Joseph Regional Medical Center, South Bend, Indiana, United States

and more 29 locations

Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Interventions
First Posted Date
2006-01-11
Last Posted Date
2023-06-29
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
100
Registration Number
NCT00274924
Locations
🇺🇸

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

🇺🇸

Mason District Hospital, Havana, Illinois, United States

🇺🇸

Greater Baltimore Medical Center Cancer Center, Baltimore, Maryland, United States

and more 99 locations

Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

Phase 2
Withdrawn
Conditions
Gastrointestinal Carcinoid Tumor
Islet Cell Carcinoma
First Posted Date
2005-09-28
Last Posted Date
2015-10-08
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00227773

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

Phase 2
Completed
Conditions
Lymphoma
Interventions
First Posted Date
2005-09-22
Last Posted Date
2023-06-18
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
46
Registration Number
NCT00217425
Locations
🇺🇸

Green Bay Oncology, Limited - Oconto Falls, Oconto Falls, Wisconsin, United States

🇺🇸

Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States

🇺🇸

California Cancer Care, Incorporated - Greenbrae, Greenbrae, California, United States

and more 107 locations
© Copyright 2025. All Rights Reserved by MedPath